Australia markets closed

Genetic Technologies Limited (GENE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.2210+0.0410 (+1.88%)
At close: 04:00PM EDT
2.2500 +0.03 (+1.31%)
After hours: 04:36PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in AUD. All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
9.864
8,686
6,795
120.554
9.864
Cost of revenue
251.511
4,335
3,014
170.457
59.525
Gross profit
-241.647
4,351
3,781
-49.903
-49.661
Operating expenses
Research development
2,478
1,281
705.507
1,166
865.627
Selling general and administrative
4,696
11,725
10,140
6,226
2,592
Total operating expenses
6,170
12,303
9,184
6,392
2,713
Operating income or loss
-6,412
-7,952
-5,402
-6,442
-2,763
Interest expense
14.823
29.515
15.215
16.338
72.08
Total other income/expenses net
305.324
-3,722
-1,485
-666.87
-1,401
Income before tax
-6,099
-11,909
-7,163
-7,078
-6,295
Income tax expense
0
-158.329
-32.125
0
0
Income from continuing operations
-6,099
-11,751
-7,131
-7,078
-6,295
Net income
-6,099
-11,751
-7,131
-7,078
-6,295
Net income available to common shareholders
-6,099
-11,751
-7,131
-7,078
-6,295
Basic EPS
-0.23
-0.36
-2.40
-2.40
-4.50
Diluted EPS
-0.23
-0.36
-2.40
-2.40
-4.50
Basic average shares
3,847
3,379
3,073
2,848
1,385
Diluted average shares
3,847
3,379
3,073
2,848
1,385